Medinex Ltd.(SG:OTX)
S$0.22+0.01 (+2.33%)
SG:OTX
Medinex Ltd. financials statements
S$0.22
At close:+0.01 (+2.33%)
Want to see SG:OTX full AI Analyst Report?
Medinex Ltd. (OTX) Ratios
3 Followers
Medinex Ltd. Ratios
SG:OTX's free cash flow for Q3 2025 was S$780.00K. For the 2025 fiscal year, SG:OTX's free cash flow was decreased by S$-76.00K and operating cash flow was S$856.00K. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.50 | 2.59 | 2.57 | 2.20 | 2.94 |
| Quick Ratio | 3.36 | 2.48 | 2.44 | 2.02 | 2.77 |
| Cash Ratio | 1.45 | 1.08 | 1.04 | 1.14 | 1.58 |
| Solvency Ratio | 0.93 | 0.85 | 0.40 | 0.51 | 0.56 |
| Operating Cash Flow Ratio | 1.11 | 1.04 | 0.89 | 0.95 | 0.94 |
| Short-Term Operating Cash Flow Coverage | 10.34 | 6.49 | 5.33 | 6.11 | 13.92 |
| Net Current Asset Value | S$ 5.54M | S$ 4.35M | S$ 3.46M | S$ 2.23M | S$ 3.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.08 | 0.10 | 0.10 | 0.17 |
| Debt-to-Equity Ratio | 0.06 | 0.10 | 0.13 | 0.13 | 0.24 |
| Debt-to-Capital Ratio | 0.06 | 0.09 | 0.11 | 0.12 | 0.19 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.02 | 0.05 | 0.07 | 0.12 |
| Financial Leverage Ratio | 1.18 | 1.24 | 1.27 | 1.29 | 1.41 |
| Debt Service Coverage Ratio | 9.23 | 6.11 | 2.93 | 4.50 | 4.78 |
| Interest Coverage Ratio | 100.95 | 92.42 | 68.78 | 57.39 | 41.49 |
| Debt to Market Cap | 0.01 | 0.03 | 0.05 | 0.07 | 0.09 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Net Debt to EBITDA | -0.84 | -0.50 | -0.60 | -0.45 | -0.68 |
| Profitability Margins | |||||
| Gross Profit Margin | 80.20% | 77.48% | 76.89% | 73.14% | 30.71% |
| EBIT Margin | 19.83% | 23.64% | 8.51% | 16.28% | 14.42% |
| EBITDA Margin | 24.12% | 27.96% | 14.26% | 22.23% | 15.69% |
| Operating Profit Margin | 33.34% | 33.36% | 30.15% | 29.44% | 27.79% |
| Pretax Profit Margin | 19.50% | 23.28% | 8.07% | 15.76% | 35.75% |
| Net Profit Margin | 17.92% | 22.12% | 8.21% | 13.11% | 32.39% |
| Continuous Operations Profit Margin | 17.92% | 22.11% | 6.89% | 13.03% | 32.95% |
| Net Income Per EBT | 91.86% | 95.02% | 101.69% | 83.18% | 90.60% |
| EBT Per EBIT | 58.49% | 69.80% | 26.78% | 53.54% | 128.63% |
| Return on Assets (ROA) | 11.42% | 13.70% | 5.04% | 7.52% | 14.91% |
| Return on Equity (ROE) | 13.46% | 16.95% | 6.41% | 9.68% | 20.97% |
| Return on Capital Employed (ROCE) | 24.29% | 24.44% | 21.73% | 19.68% | 14.84% |
| Return on Invested Capital (ROIC) | 21.67% | 22.02% | 17.70% | 15.61% | 13.19% |
| Return on Tangible Assets | 17.48% | 23.26% | 8.86% | 13.05% | 21.39% |
| Earnings Yield | 7.42% | 10.79% | 4.16% | 6.59% | 12.68% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.94 | 5.97 | 6.31 | 6.24 | 5.53 |
| Payables Turnover | 2.02 | 9.14 | 7.72 | 7.34 | 20.48 |
| Inventory Turnover | 7.34 | 7.91 | 7.56 | 6.13 | 13.31 |
| Fixed Asset Turnover | 13.75 | 14.93 | 15.32 | 13.73 | 6.83 |
| Asset Turnover | 0.64 | 0.62 | 0.61 | 0.57 | 0.46 |
| Working Capital Turnover Ratio | 2.22 | 2.60 | 2.92 | 2.59 | 1.85 |
| Cash Conversion Cycle | -57.32 | 67.29 | 58.84 | 68.28 | 75.60 |
| Days of Sales Outstanding | 73.95 | 61.09 | 57.82 | 58.46 | 66.00 |
| Days of Inventory Outstanding | 49.75 | 46.16 | 48.27 | 59.55 | 27.43 |
| Days of Payables Outstanding | 181.02 | 39.96 | 47.25 | 49.73 | 17.83 |
| Operating Cycle | 123.69 | 107.25 | 106.09 | 118.01 | 93.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
| Free Cash Flow Per Share | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
| Dividend Paid and CapEx Coverage Ratio | 1.13 | 1.49 | 1.07 | 1.40 | 2.57 |
| Capital Expenditure Coverage Ratio | 17.14 | 148.06 | 88.33 | 15.70 | 37.56 |
| Operating Cash Flow Coverage Ratio | 2.72 | 2.01 | 1.29 | 1.29 | 0.77 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.26 | 0.21 | 0.23 | 0.28 |
| Free Cash Flow Yield | 8.51% | 12.66% | 10.72% | 10.99% | 10.74% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.47 | 9.25 | 24.06 | 15.17 | 7.89 |
| Price-to-Sales (P/S) Ratio | 2.42 | 2.05 | 1.98 | 1.99 | 2.55 |
| Price-to-Book (P/B) Ratio | 1.82 | 1.57 | 1.54 | 1.47 | 1.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.76 | 7.90 | 9.32 | 9.10 | 9.31 |
| Price-to-Operating Cash Flow Ratio | 11.07 | 7.85 | 9.22 | 8.52 | 9.06 |
| Price-to-Earnings Growth (PEG) Ratio | -0.61 | 0.05 | -0.61 | -0.38 | 0.40 |
| Enterprise Value Multiple | 9.17 | 6.83 | 13.25 | 8.50 | 15.60 |
| Enterprise Value | 27.45M | 24.47M | 23.78M | 24.49M | 26.40M |
| EV to EBITDA | 9.17 | 6.83 | 13.25 | 8.50 | 15.60 |
| EV to Sales | 2.21 | 1.91 | 1.89 | 1.89 | 2.45 |
| EV to Free Cash Flow | 10.77 | 7.36 | 8.92 | 8.64 | 8.92 |
| EV to Operating Cash Flow | 10.14 | 7.31 | 8.82 | 8.09 | 8.68 |
| Tangible Book Value Per Share | 0.07 | 0.06 | 0.06 | 0.06 | 0.07 |
| Shareholders’ Equity Per Share | 0.12 | 0.13 | 0.12 | 0.13 | 0.13 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.08 | 0.05 | 0.15 | 0.17 | 0.08 |
| Revenue Per Share | 0.09 | 0.10 | 0.10 | 0.10 | 0.08 |
| Net Income Per Share | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 |
| Tax Burden | 0.92 | 0.95 | 1.02 | 0.83 | 0.91 |
| Interest Burden | 0.98 | 0.98 | 0.95 | 0.97 | 2.48 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.12 | 1.12 | 2.65 | 1.48 | 0.87 |
Currency in SGD

